eXoZymes, Inc.

US$4.40As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:EXOZHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (187.16%)
Biotechnology
Beta (5Y) 3.33
PE TTM —
TSR TTM (69.44%)
Mkt cap US$40.84M
ROIC (98.72%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.32
(1.80%)
(27.13%)
Buy 5|0|3|9|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.07
0.08
0.08
18.19%
6.20%
3.48%
9.30%
Revenue$M
2.337
2.465
2.581
2.574
0.04%
6.39%
11.86%
8.18%
Peers (US$40.84M)
Cap (US$)
PE
41.72M
—
41.60M
—
Capital
TTM
5Y
10Y
Leveragex
0.375
(0.129)
(0.110)
EBIT/Intx
0.940
0.160
0.160
Own earn%
(101.58)
(21.40)
(35.02)
Sh yield%
20.79
41.76
40.85
Owners
Insiders/Inst%
13.06
87.30
Short interest%
2.94
SBC / revenue%
0.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
27–34
$1 testx
0.0
Incr. ROIC%
3